Nexazole (Esomeprazole)

Esomeprazole, the active ingredient in Nexazole, is a Proton Pump Inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, and peptic ulcer disease in adult patients.

GNH USA supplies Nexazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Nexazole (esomeprazole) is indicated for several acid‑related conditions where suppression of gastric acid is required. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive esophagitis: promotes healing of inflamed esophageal mucosa. - Peptic ulcer disease: supports ulcer resolution and symptom control. - NSAID‑induced gastric ulcer prevention: reduces risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens for H. pylori infection.

Like all medications, esomeprazole may cause adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with diarrhea. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: skin blistering and detachment. - Hypomagnesemia: low serum magnesium with muscle cramps or arrhythmias. - Vitamin B12 deficiency: anemia and neurological symptoms with long‑term use. - Increased risk of bone fractures: especially with prolonged therapy.

Before initiating therapy, clinicians should consider several safety measures. - Assess renal function: adjust use in severe renal impairment. - Use with caution in elderly: monitor for increased fracture risk. - Avoid prolonged therapy without supervision: long‑term use may lead to nutrient deficiencies. - Monitor for drug‑induced hypomagnesemia: check serum magnesium periodically. - Store at room temperature: keep in the original container, protect from moisture and light.

Esomeprazole can affect the pharmacokinetics of several co‑administered medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: impaired antiplatelet activation.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Digoxin: increased serum concentrations. - Methotrexate: heightened toxicity risk.